SHPD002, NCT02221999: Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients |
|
|
| Active, not recruiting | 2/3 | 250 | RoW | Paclitaxel, Taxol, Cisplatin, Gonadotropin-releasing hormone agonist, Letrozole | RenJi Hospital | Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer | 01/19 | 01/29 | | |
